Cosmos Health 

$0.26
63
-$0.01-2.19% Today

Statistics

Day High
0.26
Day Low
0.26
52W High
1.25
52W Low
0.25
Volume
21,628,048
Avg. Volume
-
Mkt Cap
9.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24AugExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.53
-0.35
-0.17
0.01
Expected EPS
0.01
Actual EPS
N/A

Financials

-41.12%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
108.85MRevenue
-44.76MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow COSM. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson is a major competitor in the healthcare sector, offering a wide range of pharmaceutical, medical devices, and consumer health products that compete with Cosmos Health's offerings.
Pfizer
PFE
Mkt Cap147.62B
Pfizer is a global biopharmaceutical company that competes with Cosmos Health in the development and marketing of medications and vaccines for various diseases.
Merck
MRK
Mkt Cap302.33B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Cosmos Health in multiple healthcare areas.
Abbvie
ABBV
Mkt Cap381.1B
AbbVie is a biopharmaceutical company that engages in the discovery, development, manufacture, and sale of a broad range of pharmaceuticals, directly competing with Cosmos Health's product lines.
AMGEN
AMGN
Mkt Cap183.12B
Amgen is a biotechnology company that develops and manufactures innovative human therapeutics, competing with Cosmos Health in the biopharmaceutical sector.
Gilead Sciences
GILD
Mkt Cap166.82B
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, competing with Cosmos Health in the healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap121.42B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Cosmos Health.
Novartis
NVS
Mkt Cap290.05B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Cosmos Health in various therapeutic areas.
Roche
RHHBY
Mkt Cap343.56B
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, competing with Cosmos Health in the development of medicines and diagnostics.
Sanofi
SNY
Mkt Cap105.85B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions focused on patients' needs, competing with Cosmos Health in the global healthcare market.

About

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Show more...
CEO
Mr. Grigorios Siokas
Employees
149
Country
United States
ISIN
US2214133058

Listings

0 Comments

Share your thoughts

FAQ

What is Cosmos Health stock price today?
The current price of COSM is $0.26 USD — it has decreased by -2.19% in the past 24 hours. Watch Cosmos Health stock price performance more closely on the chart.
What is Cosmos Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cosmos Health stocks are traded under the ticker COSM.
Is Cosmos Health stock price growing?
COSM stock has risen by +1.57% compared to the previous week, the month change is a -29.99% fall, over the last year Cosmos Health has showed a -44.91% decrease.
What is Cosmos Health market cap?
Today Cosmos Health has the market capitalization of 9.05M
When is the next Cosmos Health earnings date?
Cosmos Health is going to release the next earnings report on August 24, 2026.
What were Cosmos Health earnings last quarter?
COSM earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.06 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cosmos Health revenue for the last year?
Cosmos Health revenue for the last year amounts to 108.85M USD.
What is Cosmos Health net income for the last year?
COSM net income for the last year is -44.76M USD.
How many employees does Cosmos Health have?
As of May 28, 2026, the company has 149 employees.
In which sector is Cosmos Health located?
Cosmos Health operates in the Health & Wellness sector.
When did Cosmos Health complete a stock split?
The last stock split for Cosmos Health was on December 16, 2022 with a ratio of 1:25.
Where is Cosmos Health headquartered?
Cosmos Health is headquartered in Thessaloniki, United States.